CareFusion Will Expand IV Infusion Portfolio With $225 Mil. Medegen Buy
This article was originally published in The Gray Sheet
Executive Summary
CareFusion says its planned $225 million acquisition of needleless intravenous infusion device maker Medegen will improve its ability to compete on claims of reducing hospital-acquired infections